Showing results (1-10 of 60) with videos related to

Sort By:
Pageof 6
Cancer Genomics & Proteomics|October 28, 2024
Suppressing Expression of SERPINE1/PAI1 Through Activation of GPER1 Reduces Progression of Vulvar CarcinomaTammy Doelker, Julia Gallwas, Carsten Gründker
Cancer Genomics & Proteomics|April 25, 2025
Expression of "Hallmarks of Cancer" Genes in Cervical Carcinoma Is Differentially Affected by GPER1 Overexpression Depending on Histologic EntityLena Hambach, Julia Gallwas, Carsten Gründker
Cancer Genomics & Proteomics|April 25, 2025
G-Protein-coupled Estrogen Receptor 1 (GPER1) Overexpression Affects Aggressiveness of Cervical Carcinoma Cells Depending on Histological EntityLena Hambach, Julia Gallwas, Carsten Gründker
International Journal of Molecular Sciences|May 14, 2022
Like Brothers in Arms: How Hormonal Stimuli and Changes in the Metabolism Signaling Cooperate, Leading HPV Infection to Drive the Onset of Cervical CancerMatthias Läsche, Julia Gallwas, Carsten Gründker
In Vivo (Athens, Greece)|June 30, 2026
Inhibition of Plasminogen Activator Inhibitor-1 (PAI-1) by Tiplaxtinin Attenuates the Aggressive Phenotype of Vulvar Squamous Cell Carcinoma Cells <i>In Vitro</i>Jaqueline Warmbold, Julia Gallwas, Carsten Gründker
Anticancer Research|April 28, 2025
Inhibition of Plasminogen Activator Inhibitor-1 (PAI-1) by Tiplaxtinin Reduces Aggressiveness of Cervical Carcinoma CellsSarah Wehbe, Julia Gallwas, Carsten Gründker
Cancer Genomics & Proteomics|October 28, 2025
BMP1 Appears to be Involved in GPER1-mediated Progression and Tamoxifen Resistance of Luminal A Breast Cancer CellsKatharina Wert, Johanna Jentsch, Julia Gallwas, et al.
Anticancer Research|October 26, 2022
Suppression of G Protein-coupled Estrogen Receptor 1 (GPER1) Enhances the Anti-invasive Efficacy of Selective ERβ AgonistsVivien Schmitz, Gerd Bauerschmitz, Julia Gallwas, et al.
Cells|September 28, 2021
Inhibition of Metabolism as a Therapeutic Option for Tamoxifen-Resistant Breast Cancer CellsFriederike Steifensand, Julia Gallwas, Gerd Bauerschmitz, et al.
Cancer Genomics & Proteomics|October 27, 2023
Inhibition of Increased Invasiveness of Breast Cancer Cells With Acquired Tamoxifen Resistance by Suppression of CYR61Gerd Bauerschmitz, Silke Hüchel, Julia Gallwas, et al.
Pageof 6